Cresset Asset Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-84,930
| Closed | -$1.21M | – | 2052 |
|
|
2024
Q3 | $1.21M | Sell |
84,930
-430
| -0.5% | -$6.12K | ﹤0.01% | 1046 |
|
|
2024
Q2 | $1.12M | Buy |
85,360
+8,447
| +11% | +$111K | ﹤0.01% | 980 |
|
|
2024
Q1 | $1.07M | Buy |
76,913
+19,824
| +35% | +$275K | 0.01% | 927 |
|
|
2023
Q4 | $815K | Sell |
57,089
-16,783
| -23% | -$239K | ﹤0.01% | 965 |
|
|
2023
Q3 | $1.14M | Buy |
73,872
+15,932
| +27% | +$246K | ﹤0.01% | 760 |
|
|
2023
Q2 | $921K | Buy |
+57,940
| New | +$921K | ﹤0.01% | 852 |
|
|
2021
Q4 | – | Sell |
-13,983
| Closed | -$229K | – | 1290 |
|
|
2021
Q3 | $229K | Buy |
+13,983
| New | +$229K | ﹤0.01% | 970 |
|
|
2019
Q2 | – | Sell |
-1,600
| Closed | -$33K | – | 1548 |
|
|
2019
Q1 | $33K | Buy |
+1,600
| New | +$33K | ﹤0.01% | 901 |
|